DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

SMS Pharmaceuticals Limited — Shareholders meeting

NSE 55 min ago·4 Sept 2026, 6:22 am

SMS Pharmaceuticals

SMS Pharmaceuticals has announced that its Annual General Meeting (AGM) is scheduled for September 29, 2026. This is a standard corporate procedure where the company's board and shareholders convene to approve financial statements, appoint directors, and discuss strategic matters.

For investors, this meeting is a key annual event. It provides an opportunity to review the company's performance and governance. While the specific agenda items are not yet disclosed, the outcome of the AGM can influence market sentiment regarding the firm's future direction and management stability.

Investors should watch for the official agenda and the subsequent shareholding pattern report. These documents will offer more clarity on the company's operational plans and the voting behavior of major shareholders.